Table of Contents Chapter 1 Overview of Penicillin 1.1 Definition of Penicillin in This Report 1.2 Commercial Types of Penicillin 1.2.1 Aminopenicillins 1.2.2 Antipseudomonal Penicillins 1.2.3 Beta-lactamase Inhibitors 1.2.4 Natural Penicillins 1.2.5 Penicillinase Resistant Penicillins 1.3 Downstream Application of Penicillin 1.3.1 Hospitals 1.3.2 Clinics 1.3.3 Others 1.4 Development History of Penicillin 1.5 Market Status and Trend of Penicillin 2013-2023 1.5.1 United States Penicillin Market Status and Trend 2013-2023 1.5.2 Regional Penicillin Market Status and Trend 2013-2023 Chapter 2 United States Market Status and Forecast by Regions 2.1 Market Status of Penicillin in United States 2013-2017 2.2 Consumption Market of Penicillin in United States by Regions 2.2.1 Consumption Volume of Penicillin in United States by Regions 2.2.2 Revenue of Penicillin in United States by Regions 2.3 Market Analysis of Penicillin in United States by Regions 2.3.1 Market Analysis of Penicillin in New England 2013-2017 2.3.2 Market Analysis of Penicillin in The Middle Atlantic 2013-2017 2.3.3 Market Analysis of Penicillin in The Midwest 2013-2017 2.3.4 Market Analysis of Penicillin in The West 2013-2017 2.3.5 Market Analysis of Penicillin in The South 2013-2017 2.3.6 Market Analysis of Penicillin in Southwest 2013-2017 2.4 Market Development Forecast of Penicillin in United States 2018-2023 2.4.1 Market Development Forecast of Penicillin in United States 2018-2023 2.4.2 Market Development Forecast of Penicillin by Regions 2018-2023 Chapter 3 United States Market Status and Forecast by Types 3.1 Whole United States Market Status by Types 3.1.1 Consumption Volume of Penicillin in United States by Types 3.1.2 Revenue of Penicillin in United States by Types 3.2 United States Market Status by Types in Major Countries 3.2.1 Market Status by Types in New England 3.2.2 Market Status by Types in The Middle Atlantic 3.2.3 Market Status by Types in The Midwest 3.2.4 Market Status by Types in The West 3.2.5 Market Status by Types in The South 3.2.6 Market Status by Types in Southwest 3.3 Market Forecast of Penicillin in United States by Types Chapter 4 United States Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Penicillin in United States by Downstream Industry 4.2 Demand Volume of Penicillin by Downstream Industry in Major Countries 4.2.1 Demand Volume of Penicillin by Downstream Industry in New England 4.2.2 Demand Volume of Penicillin by Downstream Industry in The Middle Atlantic 4.2.3 Demand Volume of Penicillin by Downstream Industry in The Midwest 4.2.4 Demand Volume of Penicillin by Downstream Industry in The West 4.2.5 Demand Volume of Penicillin by Downstream Industry in The South 4.2.6 Demand Volume of Penicillin by Downstream Industry in Southwest 4.3 Market Forecast of Penicillin in United States by Downstream Industry Chapter 5 Market Driving Factor Analysis of Penicillin 5.1 United States Economy Situation and Trend Overview 5.2 Penicillin Downstream Industry Situation and Trend Overview Chapter 6 Penicillin Market Competition Status by Major Players in United States 6.1 Sales Volume of Penicillin in United States by Major Players 6.2 Revenue of Penicillin in United States by Major Players 6.3 Basic Information of Penicillin by Major Players 6.3.1 Headquarters Location and Established Time of Penicillin Major Players 6.3.2 Employees and Revenue Level of Penicillin Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Penicillin Major Manufacturers Introduction and Market Data 7.1 GSK 7.1.1 Company profile 7.1.2 Representative Penicillin Product 7.1.3 Penicillin Sales, Revenue, Price and Gross Margin of GSK 7.2 Pfizer 7.2.1 Company profile 7.2.2 Representative Penicillin Product 7.2.3 Penicillin Sales, Revenue, Price and Gross Margin of Pfizer 7.3 Johnson & Johnson 7.3.1 Company profile 7.3.2 Representative Penicillin Product 7.3.3 Penicillin Sales, Revenue, Price and Gross Margin of Johnson & Johnson 7.4 Bayer HealthCare 7.4.1 Company profile 7.4.2 Representative Penicillin Product 7.4.3 Penicillin Sales, Revenue, Price and Gross Margin of Bayer HealthCare 7.5 Abbot Laboratories 7.5.1 Company profile 7.5.2 Representative Penicillin Product 7.5.3 Penicillin Sales, Revenue, Price and Gross Margin of Abbot Laboratories 7.6 Roche Pharmaceuticals 7.6.1 Company profile 7.6.2 Representative Penicillin Product 7.6.3 Penicillin Sales, Revenue, Price and Gross Margin of Roche Pharmaceuticals 7.7 Sanofi Aventis 7.7.1 Company profile 7.7.2 Representative Penicillin Product 7.7.3 Penicillin Sales, Revenue, Price and Gross Margin of Sanofi Aventis 7.8 Takeda Pharmaceutical Company 7.8.1 Company profile 7.8.2 Representative Penicillin Product 7.8.3 Penicillin Sales, Revenue, Price and Gross Margin of Takeda Pharmaceutical Company 7.9 Toyama Chemical 7.9.1 Company profile 7.9.2 Representative Penicillin Product 7.9.3 Penicillin Sales, Revenue, Price and Gross Margin of Toyama Chemical 7.10 Merck & Co. 7.10.1 Company profile 7.10.2 Representative Penicillin Product 7.10.3 Penicillin Sales, Revenue, Price and Gross Margin of Merck & Co. Chapter 8 Upstream and Downstream Market Analysis of Penicillin 8.1 Industry Chain of Penicillin 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Penicillin 9.1 Cost Structure Analysis of Penicillin 9.2 Raw Materials Cost Analysis of Penicillin 9.3 Labor Cost Analysis of Penicillin 9.4 Manufacturing Expenses Analysis of Penicillin Chapter 10 Marketing Status Analysis of Penicillin 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Aminopenicillins Table Advantage and Disadvantage of Antipseudomonal Penicillins Table Advantage and Disadvantage of Beta-lactamase Inhibitors Table Advantage and Disadvantage of Natural Penicillins Table Advantage and Disadvantage of Penicillinase Resistant Penicillins Table Consumption Volume of Penicillin in United States by Regions 2013-2017 Table Revenue of Penicillin in United States by Regions 2013-2017 Table Consumption Volume of Penicillin in United States by Regions 2018-2023 Table Revenue of Penicillin in United States by Regions 2018-2023 Table Consumption Volume of Penicillin in United States by Types 2013-2017 Table Revenue of Penicillin in United States by Types 2013-2017 Table Consumption Volume of Penicillin by Types in New England 2013-2017 Table Consumption Volume of Penicillin by Types in The Middle Atlantic 2013-2017 Table Consumption Volume of Penicillin by Types in The Midwest 2013-2017 Table Consumption Volume of Penicillin by Types in The West 2013-2017 Table Consumption Volume of Penicillin by Types in The South 2013-2017 Table Consumption Volume of Penicillin by Types in Southwest 2013-2017 Table Consumption Volume Forecast of Penicillin in United States by Types 2018-2023 Table Revenue Forecast of Penicillin in United States by Types 2018-2023 Table Demand Volume of Penicillin in United States by Downstream Industry 2013-2017 Table Demand Volume of Penicillin by Downstream Industry in New England 2013-2017 Table Demand Volume of Penicillin by Downstream Industry in The Middle Atlantic 2013-2017 Table Demand Volume of Penicillin by Downstream Industry in The Midwest 2013-2017 Table Demand Volume of Penicillin by Downstream Industry in The West 2013-2017 Table Demand Volume of Penicillin by Downstream Industry in The South 2013-2017 Table Demand Volume of Penicillin by Downstream Industry in Southwest 2013-2017 Table Demand Volume Forecast of Penicillin in United States by Downstream Industry 2018-2023 Table Sales Volume of Penicillin in United States by Major Players 2013-2017 Table Revenue of Penicillin in United States by Major Players 2013-2017 Table Headquarters Location and Established Time of Penicillin Major Players Table Employees and Revenue Level of Penicillin Major Players Table Representative Penicillin Product One of GSK Table Representative Penicillin Product Two of GSK Table Penicillin Sales, Revenue, Price and Gross Margin of GSK 2013-2017 Table Representative Penicillin Product One of Pfizer Table Representative Penicillin Product Two of Pfizer Table Penicillin Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Penicillin Product One of Johnson & Johnson Table Representative Penicillin Product Two of Johnson & Johnson Table Penicillin Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017 Table Representative Penicillin Product One of Bayer HealthCare Table Representative Penicillin Product Two of Bayer HealthCare Table Penicillin Sales, Revenue, Price and Gross Margin of Bayer HealthCare 2013-2017 Table Representative Penicillin Product One of Abbot Laboratories Table Representative Penicillin Product Two of Abbot Laboratories Table Penicillin Sales, Revenue, Price and Gross Margin of Abbot Laboratories 2013-2017 Table Representative Penicillin Product One of Roche Pharmaceuticals Table Representative Penicillin Product Two of Roche Pharmaceuticals Table Penicillin Sales, Revenue, Price and Gross Margin of Roche Pharmaceuticals 2013-2017 Table Representative Penicillin Product One of Sanofi Aventis Table Representative Penicillin Product Two of Sanofi Aventis Table Penicillin Sales, Revenue, Price and Gross Margin of Sanofi Aventis 2013-2017 Table Representative Penicillin Product One of Takeda Pharmaceutical Company Table Representative Penicillin Product Two of Takeda Pharmaceutical Company Table Penicillin Sales, Revenue, Price and Gross Margin of Takeda Pharmaceutical Company 2013-2017 Table Representative Penicillin Product One of Toyama Chemical Table Representative Penicillin Product Two of Toyama Chemical Table Penicillin Sales, Revenue, Price and Gross Margin of Toyama Chemical 2013-2017 Table Representative Penicillin Product One of Merck & Co. Table Representative Penicillin Product Two of Merck & Co. Table Penicillin Sales, Revenue, Price and Gross Margin of Merck & Co. 2013-2017